Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer DB Revenue Type — Direct Product Sales by Year
DB Revenue Type — Direct Product Sales ($M) ($M)
Pfizer DB Revenue Type — Direct Product Sales: $51,663M in FY2025, down 4.0% from a year earlier.
Latest, FY2025
51,663
Period ended Dec 31, 2025
Change on a year earlier
-4.0%
53,816 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-26) ↗
Reported in Database (SEC Form 10-K / 10-Q XBRL via lib/db.py).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | DB Revenue Type — Direct Product Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 51,663 | -4.0% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 53,816 | +5.7% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 50,914 | -44.5% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 91,793 | – | Form 10-K (filed 2025-02-27) ↗ |
Cite this data
StockData. (2026). Pfizer DB Revenue Type — Direct Product Sales ($M), annual FY2022–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/db-prod-direct
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.